Skip to main content
. 2014 Apr 23;9(4):e95881. doi: 10.1371/journal.pone.0095881

Table 4. Rates of HCV RNA undetectability during treatment stratified by ITPA deficiency.

No ITPA Deficiency (n = 48) Mild ITPA Deficiency (n = 12) Moderate ITPA deficiency (n = 9) P *
Undetectable HCV-RNA
Week 4, n(%) 21 (44%) 6 (50%) 3 (33%) 0,79
Week 8, n(%) 39 (81%) 10 (83%) 9 (100%) 0,48
Week 12, n(%) 38 (79%) 10 (83%) 9 (100%) 0,32

*No ITPA deficiency versus any ITPA deficiency.